Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch its funded epilepsy drug to Logem - which is suspected to be linked to five deaths.
National health spokesman Michael Woodhouse today released a statement again calling for a ministerial inquiry into PHARMAC's October 1 decision to change to a generic form of epilepsy drug lamotrigine.
Woodhouse said National has been requesting the ministerial inquiry into generic drug Logem since November, and made a number of allegations about the Government's handling of the patient deaths.
